• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies.

作者信息

Healy Mark A, Choti Michael A

机构信息

Banner M.D. Anderson Cancer Center, Phoenix, Gilbert, AZ, 85234, USA.

出版信息

Ann Surg Oncol. 2022 May 5. doi: 10.1245/s10434-022-11709-8.

DOI:10.1245/s10434-022-11709-8
PMID:35513591
Abstract
摘要

相似文献

1
Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies.新兴疗法背景下肝细胞癌的复发风险
Ann Surg Oncol. 2022 May 5. doi: 10.1245/s10434-022-11709-8.
2
Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.肝硬化合并小肝细胞癌患者的腹腔镜消融治疗或肝切除术
Dig Liver Dis. 2016 Feb;48(2):189-96. doi: 10.1016/j.dld.2015.11.010. Epub 2015 Nov 23.
3
Prognostic factors for hepatocellular carcinoma recurrence.肝细胞癌复发的预后因素。
World J Gastroenterol. 2014 May 28;20(20):5935-50. doi: 10.3748/wjg.v20.i20.5935.
4
Four gene intrahepatic metastasis-risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis.四个基因的肝内转移风险特征可预测肝细胞癌的恶性潜能和肝内转移的早期复发。
Surgery. 2021 Apr;169(4):903-910. doi: 10.1016/j.surg.2020.09.032. Epub 2020 Nov 5.
5
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.将改良实体瘤疗效评价标准（mRECIST）纳入Metroticket 2.0标准可改善肝移植后肝细胞癌相关死亡的预测。
J Hepatol. 2020 Aug;73(2):342-348. doi: 10.1016/j.jhep.2020.03.018. Epub 2020 Mar 20.
6
Is there a role for immunotherapy in hepatocellular carcinoma?免疫疗法在肝细胞癌中是否有作用？
Dig Liver Dis. 2006 Apr;38(4):221-5. doi: 10.1016/j.dld.2005.12.004. Epub 2006 Feb 3.
7
The management of post-transplantation recurrence of hepatocellular carcinoma.移植后肝细胞癌复发的管理。
Clin Mol Hepatol. 2022 Jan;28(1):1-16. doi: 10.3350/cmh.2021.0217. Epub 2021 Oct 5.
8
Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.原位肝移植后肝细胞癌的发病率及危险因素
Surgery. 2017 Mar;161(3):830-836. doi: 10.1016/j.surg.2016.08.049. Epub 2016 Oct 19.
9
Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.索拉非尼作为肝移植受者高危肝细胞癌辅助治疗的可行性和疗效
Exp Clin Transplant. 2010 Dec;8(4):307-13.
10
Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection.二甲双胍可降低肝癌切除术后肝癌复发的风险。
Liver Int. 2017 Mar;37(3):434-441. doi: 10.1111/liv.13280. Epub 2016 Nov 13.

引用本文的文献

1
Salvage locoregional therapies for recurrent hepatocellular carcinoma.挽救性局部区域治疗复发性肝细胞癌。
World J Gastroenterol. 2023 Jan 21;29(3):413-424. doi: 10.3748/wjg.v29.i3.413.
2
The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy.二甲双胍对根治性治疗后 2 型糖尿病合并肝细胞癌患者生存结局的影响。
Front Endocrinol (Lausanne). 2022 Dec 13;13:1060768. doi: 10.3389/fendo.2022.1060768. eCollection 2022.

本文引用的文献

1
Correction to: Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis.对《早期肝细胞癌肝切除术后复发的临床特征及复发患者的长期生存结果：一项多机构分析》的更正
Ann Surg Oncol. 2022 Aug;29(8):5206. doi: 10.1245/s10434-022-11790-z.
2
Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma.肝细胞癌患者不同手术切缘与无复发生存率的关系。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3404-9. eCollection 2015.